Adjusting anti-Müllerian hormone levels for age and body mass index improves detection of polycystic ovary syndrome
To examine whether accounting for a woman’s age and body mass index (BMI) would improve the ability of anti-Müllerian hormone (AMH) to distinguish between women with (cases) and without (controls) polycystic ovarian syndrome (PCOS).
Source: fertstert.org
Adjusting anti-Müllerian hormone levels for age and body mass index improves detection of polycystic ovary syndrome
Published in Embryology and Reproductive Medicine
More from Embryology and Reproductive MedicineMore posts in Embryology and Reproductive Medicine »
- Life after Stillbirth
- The possible impact of COVID 19 on fertility and ART
- Human embryonic stem cell–derived blastocyst-like spheroids resemble human trophectoderm during early implantation process
- What support is available for you in hospital if you lose your baby
- Estrogen receptor-α immunoreactivity predicts symptom severity and pain recurrence in deep endometriosis
Be First to Comment